KRANE FUNDS ADVISORS LLC – Bristol-Myers Squibb Company Transaction History
KRANE FUNDS ADVISORS LLC portfolio value:
$737,000
portfolio value
KRANE FUNDS ADVISORS LLC quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.05% | -110 shares | -70K | $71.09 | 10.36K |
| Q2 2022 | share | Decrease | -22.90% | -3.11K shares | -185K | $77 | 10.47K |
| Q1 2022 | share | Increase | +110.81% | 7.14K shares | 590K | $73.03 | 13.58K |
| Q4 2021 | share | Decrease | -11.21% | -814 shares | -28K | $62.52 | 6.44K |
| Q3 2021 | share | Decrease | -58.97% | -10.43K shares | -752K | $59.17 | 7.26K |
| Q2 2021 | share | Increase | +195.18% | 11.70K shares | 804K | $65.79 | 17.69K |
| Q1 2021 | share | Decrease | -43.28% | -4.57K shares | -278K | $62.15 | 5.99K |
| Q4 2020 | share | Increase | +62.88% | 4.08K shares | 265K | $60.6 | 10.56K |
| Q3 2020 | share | Decrease | -2.38% | -158 shares | 0 | $58 | 6.48K |
| Q2 2020 | share | Decrease | -18.13% | -1.47K shares | -62K | $56.14 | 6.64K |
| Q1 2020 | share | Decrease | -8.59% | -763 shares | -117K | $52.79 | 8.11K |
| Q4 2019 | share | Increase | 0.00% | 8.88K shares | 570K | $60.36 | 8.88K |